Executive Director leading enterprise-wide translational pathology biomarker efforts at a biotechnology firm. Collaborating across functions to define and implement biomarker strategy in drug development.
Responsibilities
Define the company-wide pathology and digital/ computational pathology biomarker strategy, in collaboration with key cross-functional partners, with a primary focus on oncology and immunology, but extending across all therapeutic areas
Coordinate pathology and pathology-related work across the horizon of drug development, from preclinical programs to post-marketing, in collaboration with cross-functional partners
Manage Anatomic Pathologists working within the Translational Biomarkers organization, including the Molecular Pathology biomarker laboratory lead, to foster scientific excellence and ensure alignment of pathology support with assay development
Collaborate with internal digital image analysts, on the fit-for-purpose development and application of advanced AI/ML image analysis capabilities to support therapeutic programs
Ensure application of standards and quality frameworks aligned with GLP and CAP/CLIA requirements for clinical laboratory operations
Serve as a strategic partner to Companion Diagnostics to contribute to co-development strategies and assay and image analysis algorithm validation plans for pathology-driven CDx programs
Collaborate with biomarker leads in each therapeutic area to identify pathology-enabled decision points and translate these into program-level biomarker strategies
Build and manage external collaborations with academic, technology, and industry partners to advance digital and computational pathology innovation and accelerate clinical application
Communicate scientific insights, program impact, and strategic recommendations to internal stakeholders; represent the organization through scientific presentations and publications
Requirements
Doctor of Medicine (MD) or MD/PhD required, with specialized training in Anatomic Pathology
10+ years of experience, including 5+ years of experience in a pharmaceutical or biotechnology setting
Experience in clinical biomarker development and implementation of biomarker assays to support clinical trials
Recognized leader in Anatomic Pathology with extensive experience applying digital and computational pathology approaches to translational biomarker questions
Knowledge of GLP and CAP/CLIA regulatory frameworks and experience ensuring compliance within clinical laboratory environments
Proven ability to lead cross-functional and matrixed teams, manage multiple high-priority programs, and maintain scientific rigor in fast-paced settings
Excellent communication skills with a record of impactful scientific publications and presentations
Experience with oversight of high-performing scientific teams, including direct management of scientists and physician-scientists
Benefits
medical, dental, vision healthcare and other insurance benefits (for employee and family)
retirement benefits, including 401(k)
paid holidays
vacation
compassionate and sick days
Job title
Executive Director – Distinguished Scientist, Head of Pathology Strategy – Molecular Pathology & Digital Pathology Biomarkers
Director of Development at The Nature Conservancy, spearheading fundraising efforts across Montana's landscapes. Building relationships and managing donor strategies for conserving nature.
Senior Director of Brand responsible for developing and executing brand strategies at National Geographic Society. Overseeing brand identity and collaboration with partners while maintaining brand integrity.
Executive Director leading Cal Voices, a behavioral health advocacy agency. Responsible for strategic vision, operational oversight, and stakeholder relationships in a nonprofit setting.
Director managing McDonough Career Center, developing strategies and coaching MBA students. Fostering relationships with employers and contributing to career management services.
Senior Director responsible for orchestration strategy and intelligent automation initiatives at Fox Corporation. Driving cross - functional initiatives and modernizing service delivery models across multiple functions.
Director of Inclusion and Belonging shaping GSK's workplace culture to thrive on inclusion. Leading strategies for employee engagement and managing inclusion initiatives for organizational success.
Lead global clinical studies in a biopharma company aimed at improving public health. Collaborate with cross - functional teams to ensure quality and compliance in study delivery.
Director QBP managing quality strategies and compliance in life sciences industry. Leading quality initiatives and fostering collaboration with assigned teams and third parties.
Director Clinical Pharmacology at GSK focusing on Model - Informed Drug Development. Leading strategies that ensure robust MIDD across the drug development lifecycle.